Evidence map›Paper›PMID 33633663›Full record

ArticleFrontiers in neurology2021

Case Report: Late-Onset Temporal Lobe Epilepsy Following Subarachnoid Hemorrhage: An Interplay Between Pre-existing Cortical Development Abnormality and Tissue Damage.

Anna Ikawa, Ayataka Fujimoto, Yoshifumi Arai, Yoshiro Otsuki, Toshiki Nozaki, Shimpei Baba, Keishiro Sato, Hideo Enoki

Abstract readCase Reports
In one paragraph

Article in Frontiers in neurology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Anna IkawaComprehensive Epilepsy Center, Seirei Hamamatsu General Hospital, Hamamatsu, Japan.
Ayataka FujimotoComprehensive Epilepsy Center, Seirei Hamamatsu General Hospital, Hamamatsu, Japan.
Yoshifumi AraiDepartment of Pathology, Seirei Hamamatsu General Hospital, Hamamatsu, Japan.
Yoshiro OtsukiDepartment of Pathology, Seirei Hamamatsu General Hospital, Hamamatsu, Japan.
Toshiki NozakiComprehensive Epilepsy Center, Seirei Hamamatsu General Hospital, Hamamatsu, Japan.
Shimpei BabaComprehensive Epilepsy Center, Seirei Hamamatsu General Hospital, Hamamatsu, Japan.
Keishiro SatoComprehensive Epilepsy Center, Seirei Hamamatsu General Hospital, Hamamatsu, Japan.
Hideo EnokiComprehensive Epilepsy Center, Seirei Hamamatsu General Hospital, Hamamatsu, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Epileptogenicity following brain insult depends on various factors including severity of the resulting lesion and extent of brain damage. We report a 54-year-old female patient who developed medically refractory epilepsy resulting from the interplay of pre-existing and post-insult pathologies. She presented with subarachnoid hemorrhage (SAH) due to a ruptured aneurysm and underwent clipping surgery. Seizures started 3 months post-operatively. MRI revealed cerebral ischemia and hemosiderin deposits in the left temporal lobes, and left hippocampal atrophy was suspected. As anti-seizure medications and vagus nerve stimulation failed to control her seizures, she underwent left temporal lobe resection and placement of a ventriculoperitoneal shunt for the post-operative complication of hydrocephalus. She remains seizure-free to date. Neuropathology revealed a previously undiagnosed focal cortical dysplasia (FCD) type 1a. Brain insult likely had a second hit effect in the late onset of epilepsy in this patient with pre-existing mild MCD, in whom secondary epilepsy can be attributed to the interplay of multiple underlying pathologies.

Indexed as

case reportepileptogenicityhippocampal atrophymalformation of cortical developmentmultiple pathologyparenchymal hemosiderosis

Identifiers

PMID33633663
PMCPMC7901922

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.